Christine Marie  Plummer net worth and biography

Christine Plummer Biography and Net Worth

Christine Plummer is a senior finance executive with more than 30 years of experience leading global controllership, regulatory reporting, and finance transformation across the financial services and fintech sectors. She most recently served as Global Controller at Coinbase, Inc., where she led a global controllership organization of more than 50 professionals responsible for financial close, regulatory reporting, and operational readiness for new products.

Prior to joining Coinbase, Christine was Global Deputy Controller and Managing Director at MSCI Inc., where she led the Global Commercial Revenue Controllership team of more than 70 professionals across multiple international locations. She also served as Head of Finance Transformation, leading initiatives to automate revenue contract processing, streamline operational processes, and the operational integration of acquisitions.

Earlier in her career, Christine spent more than two decades at Morgan Stanley, where she held a series of senior leadership roles including Chief Financial Officer for Americas Legal Entities, Global Head of Funding Controllers, and Global Product Controller for the Equity Division. In these roles, she led large global teams, implemented complex regulatory frameworks including SEC and CFTC Swap Dealer Rules, supported critical capital and liquidity management initiatives, and built large, multi-location finance organizations supporting the firm’s global operations.

Christine began her career as an auditor at Ernst & Young.

What is Christine Marie Plummer's net worth?

The estimated net worth of Christine Marie Plummer is at least $373.66 thousand as of April 13th, 2026. Plummer owns 489,078 shares of Biosig Technologies stock worth more than $373,656 as of August 26th. This net worth evaluation does not reflect any other assets that Plummer may own. Learn More about Christine Marie Plummer's net worth.

How do I contact Christine Marie Plummer?

The corporate mailing address for Plummer and other Biosig Technologies executives is 55 GREENS FARMS ROAD, WESTPORT, CT, 06880. Biosig Technologies can also be reached via phone at (203) 409-5444 and via email at [email protected]. Learn More on Christine Marie Plummer's contact information.

Has Christine Marie Plummer been buying or selling shares of Biosig Technologies?

Christine Marie Plummer has not been actively trading shares of Biosig Technologies over the course of the past ninety days. Most recently, Christine Marie Plummer sold 2,581 shares of the business's stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $1.08, for a transaction totalling $2,787.48. Following the completion of the sale, the chief financial officer now directly owns 486,497 shares of the company's stock, valued at $525,416.76. Learn More on Christine Marie Plummer's trading history.

Are insiders buying or selling shares of Biosig Technologies?

In the last year, Biosig Technologies insiders bought shares 12 times. They purchased a total of 1,498,011 shares worth more than $4,077,988.33. In the last year, insiders at the sold shares 6 times. They sold a total of 344,546 shares worth more than $294,659.85. The most recent insider tranaction occured on June, 12th when Chairman Morgan Lee Lekstrom bought 50,000 shares worth more than $49,500.00. Insiders at Biosig Technologies own 52.7% of the company. Learn More about insider trades at Biosig Technologies.

Information on this page was last updated on 6/12/2026.

Christine Marie Plummer Insider Trading History at Biosig Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/15/2026Sell2,581$1.08$2,787.48486,497View SEC Filing Icon  
4/13/2026Sell10,922$1.10$12,014.20489,078View SEC Filing Icon  
See Full Table

Christine Marie Plummer Buying and Selling Activity at Biosig Technologies

This chart shows Christine Marie Plummer's buying and selling at Biosig Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biosig Technologies Company Overview

Biosig Technologies logo
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Read More

Today's Range

Now: $0.76
Low: $0.73
High: $0.78

50 Day Range

MA: $0.83
Low: $0.69
High: $1.09

2 Week Range

Now: $0.76
Low: $0.66
High: $7.44

Volume

93,916 shs

Average Volume

1,708,083 shs

Market Capitalization

$88.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98